Trials / Completed
CompletedNCT00190814
Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.
Efficacy and Safety of Duloxetine Compared With Placebo in Women With Symptoms of Mixed Urinary Incontinence.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 600 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the effectiveness of duloxetine in reducing urinary incontinence(leakage of urine)occurrences in women due to physical stress and leakage that occurs during a strong need(urge) to urinate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | duloxetine | |
| DRUG | placebo |
Timeline
- Start date
- 2003-09-01
- Completion
- 2006-05-01
- First posted
- 2005-09-19
- Last updated
- 2007-01-26
Locations
3 sites across 3 countries: United States, Canada, United Kingdom
Source: ClinicalTrials.gov record NCT00190814. Inclusion in this directory is not an endorsement.